These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26463247)

  • 1. Biologic Therapy in Inflammatory Immunomediated Systemic Diseases: Safety Profile.
    Moroncini G; Albani L; Nobili L; Gabrielli A
    Curr Drug Saf; 2016; 11(1):44-6. PubMed ID: 26463247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologics in Inflammatory Immune-mediated Systemic Diseases.
    Moroncini G; Calogera G; Benfaremo D; Gabrielli A
    Curr Pharm Biotechnol; 2017; 18(12):1008-1016. PubMed ID: 29278213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic Therapy in Inflammatory and Immunomediated Skin Diseases: Safety Profile.
    Ganzetti G; Campanati A; Molinelli E; Offidani A
    Curr Drug Saf; 2016; 11(1):12-21. PubMed ID: 26463243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic Therapy in Immune Mediated Inflammatory Disease: Basic Science and Clinical Concepts.
    Molinelli E; Campanati A; Ganzetti G; Offidani A
    Curr Drug Saf; 2016; 11(1):35-43. PubMed ID: 26463248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologic Therapy in Inflammatory and Immunomediated Arthritis: Safety Profile.
    Luchetti MM; Balloni A; Gabrielli A
    Curr Drug Saf; 2016; 11(1):22-34. PubMed ID: 26463246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic Therapy in Inflammatory Eye Conditions (Ophtalmology): Safety Profile.
    Neri P; Arapi I; Nicolai M; Pirani V; Saitta A; Luchetti MM; Giovannini A; Mariotti C
    Curr Drug Saf; 2016; 11(1):47-54. PubMed ID: 26463249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic Therapy in Psoriasis: Safety Profile.
    Campanati A; Ganzetti G; Giuliodori K; Molinelli E; Offidani A
    Curr Drug Saf; 2016; 11(1):4-11. PubMed ID: 26463245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current role of rituximab in systemic lupus erythematosus.
    Mok CC
    Int J Rheum Dis; 2015 Feb; 18(2):154-63. PubMed ID: 25522652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biological therapies in systemic lupus erythematosus].
    Cairoli E; Espinosa G; Cervera R
    Rev Med Chil; 2010 Jul; 138(7):881-7. PubMed ID: 21043085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the biologic therapy of lupus: the 10 most important areas to look for common pitfalls in clinical trials.
    Medina-Rosas J; Al-Rayes H; Moustafa AT; Touma Z
    Expert Opin Biol Ther; 2016 Oct; 16(10):1225-38. PubMed ID: 27429254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic therapies in systemic lupus erythematosus.
    Bernal CB; Zamora LD; Navarra SV
    Int J Rheum Dis; 2015 Feb; 18(2):146-53. PubMed ID: 25884458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of biologic therapies for systemic lupus erythematosus treatment: systematic review and meta-analysis.
    Borba HH; Wiens A; de Souza TT; Correr CJ; Pontarolo R
    BioDrugs; 2014 Apr; 28(2):211-28. PubMed ID: 24190520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and targeted therapies of systemic lupus erythematosus: evidence and the state of the art.
    Mok CC
    Expert Rev Clin Immunol; 2017 Jul; 13(7):677-692. PubMed ID: 28443384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic therapy for autoimmune diseases: an update.
    Rosman Z; Shoenfeld Y; Zandman-Goddard G
    BMC Med; 2013 Apr; 11():88. PubMed ID: 23557513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic lupus erythematosus: an update.
    Golder V; Hoi A
    Med J Aust; 2017 Mar; 206(5):215-220. PubMed ID: 28301792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic Adverse Effects of Biologics for the Treatment of Atopy.
    Aranez V; Ambrus J
    Clin Rev Allergy Immunol; 2020 Oct; 59(2):220-230. PubMed ID: 31301006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging biological therapies for systemic lupus erythematosus.
    Mok CC
    Expert Opin Emerg Drugs; 2014 Jun; 19(2):303-22. PubMed ID: 24588398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Safety and efficacy of off-label use of biologic therapies in patients with inflammatory rheumatic diseases refractory to standard of care therapy : Data from a nationwide German registry (GRAID2)].
    Proft F; Schulze-Koops H; Grunke M; Schrezenmeier E; Halleck F; Henes J; Unger L; Schmidt E; Fiehn C; Jacobi A; Iking-Konert C; Kneitz C; Schmidt RE; Bannert B; Voll RE; Fischer-Betz R; Kötter I; Tony HP; Holle J; Aringer M; Erler A; Behrens F; Burmester GR; Dörner T
    Z Rheumatol; 2018 Feb; 77(1):28-39. PubMed ID: 28589389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New biologic therapy for systemic lupus erythematosus.
    Ding HJ; Gordon C
    Curr Opin Pharmacol; 2013 Jun; 13(3):405-12. PubMed ID: 23664092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is B Cell-Targeted Therapy Effective in Systemic Lupus Erythematosus?
    Paran D; Naparstek Y
    Isr Med Assoc J; 2015 Feb; 17(2):98-103. PubMed ID: 26223085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.